3rd Quarter - Amendment

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$207,464
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 23, 2008 $207,464 Replaced
3rd Quarter - Termination Aug 25, 2009 $207,464 Replaced
3rd Quarter - Amendment (this page) Oct 20, 2009 $207,464 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health & Human Services (HHS) anthrax vaccine and antitoxin. Avanced research and development. BARDA funding. Project Bioshield. Biodefense

LobbyistCovered position, as disclosed
MARK EDWARD COOKE Lobbyist, Government Affairs

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.